Qube Research & Technologies (QRT)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,016,238
Closed -$205M 3685
2025
Q4
$205M Buy
+2,016,238
New +$162M 0.21% 92
2024
Q3
Sell
-34
Closed -$1.44K 3531
2024
Q2
$1.44K Sell
34
-425,597
-100% -$23.4M ﹤0.01% 3217
2024
Q1
$29.4M Sell
425,631
-620,276
-59% -$39.2M 0.05% 451
2023
Q4
$77.4M Buy
1,045,907
+505,716
+94% +$33.1M 0.15% 162
2023
Q3
$36.9M Buy
540,191
+414,059
+328% +$35.1M 0.1% 259
2023
Q2
$11.8M Sell
126,132
-20,242
-14% -$1.58M 0.04% 492
2023
Q1
$9.93M Buy
+146,374
New +$9.41M 0.04% 473
2022
Q4
Sell
-197,169
Closed -$6.41M 2619
2022
Q3
$6.41M Buy
+197,169
New +$8.13M 0.04% 537
2021
Q1
Sell
-44,378
Closed -$5.88M 2050
2020
Q4
$5.88M Buy
+44,378
New +$5.37M 0.08% 272

Other funds holding EXAS

Qube Research & Technologies (QRT)'s EXAS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,016,238 shares — an estimated $205M sold.

Qube Research & Technologies (QRT) first reported a position in EXAS in Q4 2020 and held it in 9 quarters. The position peaked at $205M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,016,238 Exact Sciences shares in Q1 2026, an estimated $205M.
  • Qube Research & Technologies (QRT) first reported a position in Exact Sciences in Q4 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Exact Sciences position peaked at $205M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.